Ameriprise’s BlackRock ESG Capital Allocation Term Trust ECAT Stock Holding History
Bought
Maintained
Sold
Other funds holding ECAT
SCM
PCM
AAM
Ameriprise's ECAT Position: Q2 2026 in Review
Ameriprise increased its BlackRock ESG Capital Allocation Term Trust (ECAT) stake by 27% in Q2 2026, buying an estimated $2.58M and bringing the position to 813,493 shares worth $12.8M. The position accounts for ﹤0.01% of the portfolio, ranked #1872.
Ameriprise first reported a position in ECAT in Q4 2021 and has held it in 19 quarters since. 79 funds tracked by Wall St. Rank hold ECAT as of Q2 2026.
- Ameriprise held 813,493 shares of BlackRock ESG Capital Allocation Term Trust worth $12.8M as of Q2 2026.
- Ameriprise bought 170,907 BlackRock ESG Capital Allocation Term Trust shares in Q2 2026, an estimated $2.58M.
- BlackRock ESG Capital Allocation Term Trust made up ﹤0.01% of Ameriprise's portfolio in Q2 2026, its #1872 holding.
- Ameriprise first reported a position in BlackRock ESG Capital Allocation Term Trust in Q4 2021 and has held it in 19 quarters since.
- 79 funds tracked by Wall St. Rank held BlackRock ESG Capital Allocation Term Trust as of Q2 2026.
Based on Ameriprise's 13F filing for Q2 2026, filed 14 Aug 2026.